FEASIBILITY AND SAFETY OF ALLOGENEIC EX VIVO ACTIVATED-NK CELL INFUSION AFTER MATCHED RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A PROSPECTIVE PHASE I TRIAL

被引：0
|
作者：
Calmels, B. [1 ]
Devillier, R. [2 ]
Guia, S. [3 ]
Mfarrej, B. [1 ]
Furst, S. [2 ]
Harbi, S. [2 ]
Granata, A. [2 ]
Faucher, C. [2 ]
Izadifar, F. [2 ]
Makni, B. [1 ]
Vicari, O. [1 ]
Lignee, P. [1 ]
Lemarie, C. [1 ]
Fauriat, C. [4 ]
Olive, D. [4 ]
Vivier, E. [3 ]
Chabannon, C. [1 ]
Ugolini, S. [3 ]
Blaise, D. [2 ]
机构：
[1] Inst Paoli Calmettes, Ctr Therapie Cellulaire, Marseille, France
[2] Inst Paoli Calmettes, Unite Transplantat & Therapie Cellulaire, Marseille, France
[3] Ctr Immunol Marseille Luminy, Marseille, France
[4] Inst Paoli Calmettes, Lab Immunomonitoring, Marseille, France
来源：
CYTOTHERAPY | 2017年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
22
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [31] The prognostic value of oxygenation index early after allogeneic hematopoetic stem cell transplantation:: results of a prospective trial
    Schiemanck, CS
    Höffken, G
    Ehninger, G
    Bornhäuser, M
    Illmer, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S45 - S45
  • [32] Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study
    Shah, Nina
    Li, Li
    Kaur, Indreshpal
    McCarty, Jessica
    Yvon, Eric
    Shaim, Hila
    Muftuoglu, Muharrem
    Liu, Enli
    Sobieski, Catherine
    Orlowski, Robert Z.
    Cooper, Laurence J. N.
    Lee, Dean A.
    Parmar, Simrit
    Cao, Kai
    Hosing, Chitra M.
    Ahmed, Sairah
    Nieto, Yago
    Bashir, Qaiser
    Patel, Krina K.
    Bollard, Catherine M.
    McNiece, Ian K.
    Qazilbash, Muzaffar
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    BLOOD, 2015, 126 (23)
  • [33] Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
    Caballero-Velazquez, Teresa
    Montero, Isabel
    Sanchez-Guijo, Fermin
    Parody, Rocio
    Saldana, Raquel
    Valcarcel, David
    Lopez-Godino, Oriana
    Ferra i Coll, Christelle
    Cuesta, Marian
    Carrillo-Vico, Antonio
    Sanchez-Abarca, Luis I.
    Lopez-Corral, Lucia
    Marquez-Malaver, Francisco J.
    Perez-Simon, Jose A.
    CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5673 - 5681
  • [34] Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial
    Ciurea, Stefan O.
    Lee, Dean A.
    Denman, Cecele
    Schafer, Jolie
    Bassett, Roland L., Jr.
    Cao, Kai
    Rondon, Gabriela
    Chen, Julianne
    Soebbing, Doris
    Willis, Dana B.
    Ahmed, Sairah
    Bashir, Qaiser
    Kebriaei, Partow
    Khouri, Issa F.
    Oran, Betul
    Parmar, Simrit
    Popat, Uday R.
    Hosing, Chitra
    Yvon, Eric
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Champlin, Richard E.
    BLOOD, 2016, 128 (22)
  • [35] PHASE I/II STUDY ON INFUSION OF ALLOREACTIVE OR EX VIVO IL-15 STIMULATED NK CELLS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA
    Mestre, Carmen
    Leon Triana, Odelaisy
    Navarro Zapata, Alfonso
    Bueno, David
    Sisinni, Luisa
    Badell Serra, Isabel
    Gonzalez Vicent, Marta
    Belendez, Cristina
    Clares Villa, Laura
    Mozo, Yasmina
    Al-Akioui, Karima
    Galan, Victor
    Guerra, Pilar
    Echecopar, Carlos
    Bareke, Halin
    Aguirre, Cristina
    Perez Martinez, Antonio
    BONE MARROW TRANSPLANTATION, 2024, 59 : 238 - 239
  • [36] Adoptive transfer of ex vivo streptamer-enriched CMV-specific CD8 T cells in patients after allogeneic hematopoietic stem cell transplantation - a phase I/II trial
    Neuenhahn, M.
    Grigoleit, G. U.
    Tonn, T.
    Odendahl, M.
    Germeroth, L.
    Busch, D. H.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 34 - 34
  • [37] Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation - Results From The Prospective German Multicenter Validation Trial
    Wolff, Daniel
    Herzberg, Philipp Y.
    Pavletic, Steven Z.
    Heussner, Pia
    Mumm, Friederike
    Balsiger, Christina
    Hilgendorf, Inken
    Hemmati, Philipp
    Holler, Ernst
    Greinix, Hildegard T.
    Mitchell, Sandra A.
    BLOOD, 2013, 122 (21)
  • [38] Comorbidity significantly impairs quality of life in patients after allogeneic hematopoietic stem cell transplantation - results from the prospective german multicenter validation trial
    Krause, C.
    Herzberg, P. Y.
    Pavletic, S. Z.
    Heussner, P.
    Mumm, F.
    Balsiger, C.
    Hilgendorf, I
    Hemmati, P.
    von Harsdorf, S.
    Herr, W.
    Holler, E.
    Greinix, H.
    Mitchell, S. A.
    Wolff, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 190 - 190
  • [39] Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial
    Chen, Yi-Bin
    Mohty, Mohamad
    Zeiser, Robert
    Teshima, Takanori
    Jamy, Omer
    Maertens, Johan
    Purtill, Duncan
    Chen, Jingjing
    Cao, Hong
    Rossiter, Guillermo
    Jansson, Johan
    Floisand, Yngvar
    NATURE MEDICINE, 2024, 30 (08) : 2277 - 2287
  • [40] Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease
    Raines, Lydia N.
    Hsieh, Matthew M.
    Nassehi, Tina
    Drysdale, Claire M.
    Tisdale, John F.
    Uchida, Naoya
    CYTOTHERAPY, 2019, 21 (12) : 1206 - 1215
12345